Physicians achieve 95% cure rate for sickle cell disease with bone marrow transplant

A reduced-intensity bone marrow transplant regimen developed by Johns Hopkins physicians provides durable engraftment with low rejection rates and also may preserve fertility, according to results of a new study conducted by Johns Hopkins Kimmel Cancer Center investigators. The work is published in the journal Blood Advances.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup